Prevention of Opioid-Induced Nausea and Vomiting during Treatment of Moderate to Severe Acute Pain: A Randomized Placebo-Controlled Trial Comparing CL-108 (Hydrocodone 7.5 mg/Acetaminophen 325 mg/Rapid-Release, Low-Dose Promethazine 12.5 mg) with Conventional Hydrocodone 7.5 mg/Acetaminophen 325 mg

John R. Zuniga, Athena S. Papas, Stephen E. Daniels, Kyle Patrick, Derek D. Muse, Daniel Oreadi, Helen E. Giannakopoulos, Eric J. Granquist, Lawrence M. Levin, Joli C. Chou, Hilda Maibach, Bernard P. Schachtel

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Prevention of Opioid-Induced Nausea and Vomiting during Treatment of Moderate to Severe Acute Pain: A Randomized Placebo-Controlled Trial Comparing CL-108 (Hydrocodone 7.5 mg/Acetaminophen 325 mg/Rapid-Release, Low-Dose Promethazine 12.5 mg) with Conventional Hydrocodone 7.5 mg/Acetaminophen 325 mg'. Together they form a unique fingerprint.

Prevention of Opioid-Induced Nausea and Vomiting during Treatment of Moderate to Severe Acute Pain: A Randomized Placebo-Controlled Trial Comparing CL-108 (Hydrocodone 7.5 mg/Acetaminophen 325 mg/Rapid-Release, Low-Dose Promethazine 12.5 mg) with Conventional Hydrocodone 7.5 mg/Acetaminophen 325 mg

Fingerprint

Medicine & Life Sciences